Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
Clinical trial NCT00411528 · COMPLETED
Trial details
- NCT number
- NCT00411528
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.